Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Kedudukan dalam Saham #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Harga Saham
$0.04406501
Disegerakkan terakhir: 2024-07-09
Modal Pasaran
$23.47M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan InDex Pharmaceuticals Holding AB (publ) (INDEX)

Kategori

EPS untuk InDex Pharmaceuticals Holding AB (publ) (INDEX)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham InDex Pharmaceuticals Holding AB (publ), EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk InDex Pharmaceuticals Holding AB (publ) dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 -
US
$-7.98 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH